HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

942.615

0.000

Number of Gainers:5

Number of Losers:4

Number of Flat:8

PE:- -

High:942.615

Open:942.615

Low:942.615

Close:942.615

Volume:- -

Turnover:- -

Market Cap:638.44B

Float Cap:527.72B

Loading ...

Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

JD Health International Stock Sheds 1.5% in Hong Kong

BYD Electronic (International) Stock Rises 2.1% in Hong Kong

Alibaba Health Information Technology Stock Slips 2.2% in Hong Kong

Ascletis Pharma (SEHK:1672) At 5x P B On Obesity Trial Momentum Looks About Right

Simply Wall St.

Pharmaceutical Research Surpasses Semiconductor in Interest, Innovative Drug Sector Retreats, Huabao Fund's Hong Kong Biotech ETF Falls Below Key Moving Average, CXO Shows Resilience with WuXi Companies Rising Against the Trend

CSPC Pharma Starts Phase 1 Trial of CAR-T Drug for Relapsed, Refractory Lupus

MT Newswires Live

August Fund Launch Supply Dips, Healthcare Sector Attracts Contrarian Investment

China A-Share Key Announcements: A 5x Surge Stock Issues Urgent Clarification; Six-Day Limit-Up Pharma Leader Warns of Risks

CSPC Pharma's SYS 6063 Trial for Lupus Clears First Site in China

CSPC Pharmaceutical - Pharma Initiates Phase I Trial of Sys6063 for Relapsed, Refractory Sle in China

THOMSON REUTERS

Sinopharm Group Stock Slides 1.3% in Hong Kong

JD Health International Stock Sheds 1.6% in Hong Kong

China Passenger Car Market Retail Sales Dropped 20.9% Year-on-Year in July, According to Industry Data

Baiyunshan Pharmaceutical Gets Nod to Trial New Indication for Zhangyanming Tablets

MT Newswires Live

Morning Session Sees Market Divergence With ChiNext Up 1.41%, MLCC and Pharmaceuticals Lead Gains

Hong Kong Stock Moves: Kintor Pharma-B (09939) Surges Nearly 9% Again, Subsidiary Signs Strategic Framework with Shanghai Kangmei for KT-939

Junshi Biosciences Shareholder Cuts Stake

MT Newswires Live

JUNSHI BIO Shareholder He Ming Completes Sale of 882,600 Shares, Fulfilling Reduction Plan

Ascletis Pharma Begins Obesity Drug Candidate Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK1515/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":942.61523,"timestamp":1787534969917,"preClose":942.61523,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Pre-opening","change":0,"latestTime":"08-24 09:29:29","open":942.61523,"high":942.61523,"low":942.61523,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"pbRate":1.422618,"peRate":17.199147,"turnoverRate":0.006409,"increases":0,"decrements":0,"flats":17,"marketCap":638437625280,"floatMarketCap":527721925568},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":942.61523,"amplitude":0,"preClose":942.61523,"low":942.61523,"pbRate":"1.422618","latestPrice":942.61523,"volume":0,"delay":0,"open":942.61523,"prevYearClose":1190.107,"prevWeekClose":942.615,"prevMonthClose":925.972,"prevQuarterClose":802.777,"fiveDayClose":915.795,"twentyDayClose":908.671,"sixtyDayClose":923.442,"secType":"PLATE","market":"HK","turnoverRate":0.006409,"peRate":17.199147,"marketCap":638437625280,"floatMarketCap":527721925568,"timestamp":1787534969936,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":5,"down":4,"flat":8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658920953","title":"Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658920953","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658920953?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:33","pubTimestamp":1786523580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 1.5% to 4.93 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.8% to 25440.17.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 46% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.3% and Amgen Inc. remained unchanged.Trading volume totaled 51.4 million shares, compared to the 50-day average of 99.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","PJP","BK1521","TBXU","BBH","LU1023059063.AUD","LU1061106388.HKD","IBB","IE00B4R5TH58.HKD","LU2468319806.SGD","BK1589","01177","LU0058720904.USD","IBBQ","LU0889565916.HKD","LU2242652126.USD","BK1515","LU0289739699.SGD","BK4566","BK4599","LU0868494617.USD","LU1571399168.USD","SG9999001440.SGD","BK4139","LU2242646821.SGD","PBE","AMGN","IE00BZ08YT58.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU2089984988.USD","IE0009355771.USD","IE0002141913.USD","IE00BZ08YS42.EUR","LU2112291526.USD","IE00BJJMRZ35.SGD","BK4534","LU1983299246.USD","IE00BZ08YR35.GBP","BK4533","LU0109394709.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4581","LU1057294990.SGD","BIB","LU0320765992.SGD","HK0000165453.HKD","BK1191","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658892920","title":"JD Health International Stock Sheds 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2658892920","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658892920?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:33","pubTimestamp":1786523580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. shed 1.5% to 38.86 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.8% to 25440.17.This was the stock's second consecutive day of losses.JD Health International Inc. closed 46% below its 52-week high of HK$71.70, which the company reached Jan. 15.Trading volume totaled 5.5 million shares, compared to the 50-day average of 10.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1247","SGXZ62798434.SGD","BK1142","86618","SGXZ86797644.SGD","BK1615","LU0051755006.USD","BK1571","BK1591","BK1515","BK1583","BK1589","06618","LU0456827905.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658867920","title":"BYD Electronic (International) Stock Rises 2.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2658867920","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658867920?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:32","pubTimestamp":1786523520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. rose 2.1% to 23.82 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.8% to 25440.17.BYD Electronic  Co. Ltd. closed 49% below its 52-week high of HK$46.70, which the company achieved Sept. 2.The stock outperformed some of its competitors, as Times Universal Group Holdings Ltd. fell 2.3%.Trading volume totaled 11.9 million shares, compared to the 50-day average of 12.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1149","LU0274383008.USD","00285","BK1580","BK1582","LU0348766576.USD","BK1167","BK1504","BK1589","BK1607","BK1515","LU0348767384.USD","BK1540"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658692086","title":"Alibaba Health Information Technology Stock Slips 2.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2658692086","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658692086?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:32","pubTimestamp":1786523520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. slipped 2.2% to 3.33 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.8% to 25440.17.This was the stock's second consecutive day of losses.Alibaba Health Information Technology Ltd. closed 58% below its 52-week high of HK$7.91, which the company reached Jan. 14.The stock underperformed when compared to some of its competitors, as HKT Trust & HKT Ltd. fell 0.7%.Trading volume totaled 98.8 million shares, compared to the 50-day average of 113.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1571","BK1142","BK1617","83115","BK1591","HK0000165453.HKD","03115","BK1247","BK1589","HSTECH","07300","03419","BK1615","02833","HSI","07200","07500","BK1189","02800","513600","BK1502","BK1610","BK1584","00241","BK1501","82800","03037","HHImain","09115","BK1515","MCHmain","MHImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658128927","title":"Ascletis Pharma (SEHK:1672) At 5x P B On Obesity Trial Momentum Looks About Right","url":"https://stock-news.laohu8.com/highlight/detail?id=2658128927","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658128927?lang=en_us&edition=fundamental","pubTime":"2026-08-12 15:30","pubTimestamp":1786519859,"startTime":"0","endTime":"0","summary":"Ascletis Pharma (SEHK:1672) has drawn fresh attention after launching two Phase I obesity trials in the U.S. and starting a global Phase III program for its oral GLP-1 candidate ASC30.\nSee our latest analysis for Ascletis Pharma.\nThe recent obesity pipeline updates arrive after a mixed share price run for Ascletis Pharma. The stock rose 13.29% over a 7 day share price return but remains down 37.61% over a 90 day share price return and has recorded a 26.41% decline on the 1 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/ascletis-pharma-sehk1672-at-5x-p-b-on-obesity-trial-momentum","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/ascletis-pharma-sehk1672-at-5x-p-b-on-obesity-trial-momentum","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1515","01672","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107205780","title":"Pharmaceutical Research Surpasses Semiconductor in Interest, Innovative Drug Sector Retreats, Huabao Fund's Hong Kong Biotech ETF Falls Below Key Moving Average, CXO Shows Resilience with WuXi Companies Rising Against the Trend","url":"https://stock-news.laohu8.com/highlight/detail?id=1107205780","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107205780?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:16","pubTimestamp":1786504593,"startTime":"0","endTime":"0","summary":"On August 12, the previously rising Hong Kong-listed innovative drug supply chain experienced a correction. The medical-themed sector in Hong Kong Stock Connect traded sideways below the waterline,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1161","09939","BK4535","FTXL","159582","SOXQ","BK4585","MQQQ","SOXS","SOXX","CHPS","06978","WX","SOXL","SOXY","FWD","BK1515","FLHK","NBDS","USD","MEDX","TEKX","PSI","SMHU","CXO","SMH","LNGR","159938","159316","EIS","SMHX","SSG","BK4588","IBBQ","XSD","CHPY","CWC","BK1574","TECY","VGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658942043","title":"CSPC Pharma Starts Phase 1 Trial of CAR-T Drug for Relapsed, Refractory Lupus","url":"https://stock-news.laohu8.com/highlight/detail?id=2658942043","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658942043?lang=en_us&edition=fundamental","pubTime":"2026-08-12 09:23","pubTimestamp":1786497820,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical (HKG:1093) said Phase 1 clinical trial of its SYS6063 CAR-T therapy for relapsed/refractory systemic lupus erythematosus has begun at its first clinical center in China, according ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1951186391.HKD","LU0067412154.USD","LU0326950275.SGD","HK0000165453.HKD","BK4230","01093","IE00BZ08YS42.EUR","LU0072913022.USD","LU0501845795.SGD","LU2039709279.SGD","LU1226287792.SGD","IE00B5MMRT66.SGD","IE0008368742.USD","LU1807302812.USD","BK1521","LU0314109678.HKD","LU1226287529.USD","BK4022","LU1008478684.HKD","BK1191","LU1993786604.SGD","IE0008369823.USD","LU0880133367.SGD","LU1226288170.HKD","LU1152091168.USD","CAR","LU0315179316.USD","LU1226288253.USD","LU1813983027.USD","IE00BZ08YR35.GBP","IE00B543WZ88.USD","LU1226287875.USD","IE00BZ08YT58.USD","LU1328277881.USD","LU1960683339.HKD","LU1152091754.HKD","IE00B031HY20.USD","LU0140636845.USD","BK1515","SG9999004220.SGD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158258692","title":"August Fund Launch Supply Dips, Healthcare Sector Attracts Contrarian Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=1158258692","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158258692?lang=en_us&edition=fundamental","pubTime":"2026-08-12 07:10","pubTimestamp":1786489855,"startTime":"0","endTime":"0","summary":"August has seen a weakening in the overall supply of new public mutual fund launches, driven by market volatility in July. As of August 11, Wind data shows only 23 new funds were established this...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","159938","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119395738","title":"China A-Share Key Announcements: A 5x Surge Stock Issues Urgent Clarification; Six-Day Limit-Up Pharma Leader Warns of Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=1119395738","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119395738?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:20","pubTimestamp":1786450855,"startTime":"0","endTime":"0","summary":"Today's Market Focus Foxconn Industrial Internet Co., Ltd. (601138) reported a net profit of RMB 23.74 billion for the first half of 2026, a 95.99% year-on-year increase. Revenue reached RMB 557.861...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","BK1574","399300","BK1515","BK1161","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103582360","title":"CSPC Pharma's SYS 6063 Trial for Lupus Clears First Site in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1103582360","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103582360?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:09","pubTimestamp":1786450140,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that the Phase I clinical trial of its investigational therapy, SYS 6063, for refractory systemic lupus erythematosus (SLE) has officially commenced at the first...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","LU1328277881.USD","LU1226287792.SGD","LU1813983027.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1993786604.SGD","BK1191","IE0008368742.USD","IBBQ","LU2039709279.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","KURE","LU0501845795.SGD","LU0072913022.USD","LU0067412154.USD","LU1951186391.HKD","LU0140636845.USD","LU0314109678.HKD","IBBJ","SG9999004220.SGD","LU1807302812.USD","LU1960683339.HKD","LU1226287529.USD","LU1226288170.HKD","BK1515","IE0008369823.USD","LU0326950275.SGD","IE00BZ08YT58.USD","BK1521","LU0315179316.USD","MDTX","HK0000165453.HKD","LU1226287875.USD","01093","LU1226288253.USD","BMED","LU0880133367.SGD","IE00B031HY20.USD","PSYK","LU1008478684.HKD","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990824","title":"CSPC Pharmaceutical - Pharma Initiates Phase I Trial of Sys6063 for Relapsed, Refractory Sle in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990824","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990824?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:02","pubTimestamp":1786449766,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN4480FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0314109678.HKD","IE00BZ08YR35.GBP","SG9999004220.SGD","LU0326950275.SGD","KURE","LU1951186391.HKD","LU0140636845.USD","IE00BZ08YT58.USD","01093","LU1008478684.HKD","LU1226287529.USD","LU1226288253.USD","LU1226288170.HKD","LU1960683339.HKD","LU1807302812.USD","LU1152091754.HKD","LU1226287792.SGD","BK1521","LU2039709279.SGD","LU0067412154.USD","LU1993786604.SGD","IE00B031HY20.USD","LU0315179316.USD","BK1191","LU0880133367.SGD","IE00B543WZ88.USD","LU1226287875.USD","LU0501845795.SGD","LU1813983027.USD","LU0072913022.USD","LU1152091168.USD","IE00B5MMRT66.SGD","BK1515","LU1328277881.USD","IE0008369823.USD","HK0000165453.HKD","IE0008368742.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658993953","title":"Sinopharm Group Stock Slides 1.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2658993953","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658993953?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:33","pubTimestamp":1786437180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. shed 1.3% to 16.83 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.1% to 25652.82.Sinopharm Group Co. Ltd. closed 25% short of its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.2%.Trading volume totaled 3.4 million shares, compared to the 50-day average of 6.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","BK0028","BK0060","BK1500","01099","BK0012","SHTDY","02196","BK1197","LU0640798160.USD","BK4175","600196","BK1191","BK0239","BK1593","BK0196","BK0188","BK1515","LU1115378108.SGD","BK0187","BK0096","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658993956","title":"JD Health International Stock Sheds 1.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2658993956","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658993956?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:32","pubTimestamp":1786437120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. slid 1.6% to 39.44 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.1% to 25652.82.JD Health International Inc. closed 45% short of its 52-week high of HK$71.70, which the company reached Jan. 15.Trading volume totaled 7.4 million shares, compared to the 50-day average of 10.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1247","HSI","BK1571","BK1591","513600","BK1515","LU0456827905.SGD","03115","HSTECH","83115","BK1142","SGXZ86797644.SGD","BK1615","LU0051755006.USD","BK1583","BK1589","02833","MHImain","07500","03419","09115","82800","07300","02800","SGXZ62798434.SGD","03037","86618","MCHmain","06618","HHImain","07200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164022889","title":"China Passenger Car Market Retail Sales Dropped 20.9% Year-on-Year in July, According to Industry Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1164022889","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164022889?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:29","pubTimestamp":1786436990,"startTime":"0","endTime":"0","summary":"The China Passenger Car Association (CPCA) has released data showing that nationwide passenger car retail sales reached 1.461 million units in July 2026, marking a 20.9% decline compared to the same...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2750360997.AUD","LU1551013342.USD","LU2756315664.SGD","LU0516422440.USD","TSLR","LU0327786744.USD","TSLQ","LU0345770993.USD","LU0871576103.HKD","BK1504","LU1267930730.SGD","TSLZ","LU1066051811.HKD","GWLLY","LU0128522744.USD","LU0054450605.USD","LU1066051498.USD","LU0348723411.USD","LU0594300419.USD","FDRV","09366","LU0345769128.USD","LU0823038988.USD","IE00B1BXHZ80.USD","TSII","LU0316494557.USD","LU1580142542.USD","LU1997244956.HKD","LU1146622755.USD","09766","BK0070","LU2153592121.USD","LU0289960550.SGD","LU2476274720.SGD","LU1674673428.USD","IE0034235303.USD","LU0039217434.USD","LU0511384066.AUD","LU0164865239.USD","BK1594","LU0077335932.USD","LU2506951792.HKD","LU0259732245.USD","BK1607","BK0264","LU0588545490.SGD","LU1328277881.USD","IE00B19Z8X17.USD","SG9999002828.SGD","TSLG","IE00BK4W5L77.USD","LU1781817850.SGD","LU1861219969.SGD","LU2462157665.USD","BK1149","HK0000914660.USD","LU0175139822.USD","BK4585","LU1868837722.USD","BK1610","BK0169","LU0689472784.USD","LU0823039010.USD","IE00BK4W5M84.HKD","ELOL","LU2580892789.USD","IE00BD6J9T35.USD","SG9999015986.USD","LU0359201885.HKD","LU1861220033.SGD","LU2417539215.USD","LU0819121731.USD","BK4598","LU0056508442.USD","LU0650527681.SGD","BK1589","LU2360106780.USD","LU2750360641.GBP","SG9999001226.SGD","LU0543330566.HKD","TSLS","LU1251922891.USD","LU1720051017.SGD","LU0084288322.USD","LU2471134952.CNY","EVS.SI","TSL","LU0320764243.SGD","TESL","SMOG","BK0196","IE00BWXC8680.SGD","BK4527","LU0348827113.USD","LU0572944931.SGD","BK4099","LU0856984785.SGD","LU1232071149.USD","LU0561508036.HKD","LU2290526834.HKD","TLA","LU0348805143.USD","LU0323591593.USD","LU2087621335.USD","LU2168564065.EUR","LU1770034418.SGD","LU0417516738.SGD","LU2148510915.USD","LU2778985437.USD","LU2097828474.EUR","LU1852331112.SGD","LU0516423174.USD","BK4588","BK1119","LU0307460666.USD","LU0043850808.USD","LU0053666078.USD","LU2602419157.SGD","LU0531971595.HKD","LU1064130708.USD","LU0348766576.USD","TSLT","WATS","07766","TSLA","TSLI","LU1066051225.USD","IDRV","LU0229945570.USD","LU0463099449.HKD","LU2399975544.HKD","LU2449936058.SGD","81211","LU0672654240.SGD","LU0320765059.SGD","LU2249611893.SGD","LU0244354667.USD","LU0683595622.HKD","LIT","IE00B19Z8W00.USD","LU0865486749.SGD","LU0943347566.SGD","LU1868837565.USD","BK1580","LU1839511570.USD","BK4555","LU1242518857.USD","LU1429558221.USD","LU1808992512.USD","LU2476274308.USD","07366","SG9999006514.SGD","LU0469268626.HKD","LU0719512351.SGD","LU0029874905.USD","CRSH","IE00B1XK9C88.USD","TEST","LU0314109678.HKD","LU0348767384.USD","LU1880383440.USD","LU2326559502.SGD","LU1794554557.SGD","LU2236285917.USD","BK0155","LU0133085943.USD","LU2097828805.USD","LU2580892862.HKD","LU1066053197.SGD","BK4604","LU0082616367.USD","BK4612","LU0708995583.HKD","BK1515","LU0326950275.SGD","LU0143863198.USD","LU0254981946.USD","BK0014","LU0234572021.USD","LU0540923850.HKD","HYDD.SI","BK4550","LU2213496289.HKD","LU2328871848.SGD","LU0348735423.USD","LU0164872284.USD","TSLY","LU2495084118.USD","WANT","LU1861558580.USD","LU2289578879.USD","HOmain","TSLL","LU1861559042.SGD","LU2039709279.SGD","LU2168564222.USD","LU2294711713.HKD","LU0823411888.USD","LU0531970944.HKD","LU0820561909.HKD","LU0315178854.USD","LU0516423091.SGD","LU0165289439.USD","LU1997245177.USD","LU1778281490.HKD","LU2471134523.USD","BK4534","BK4516","LU0214875030.USD","LU2360107325.USD","LU0345770308.USD","LU0359202008.SGD","LU1914381329.SGD","SG9999015978.USD","TSLP","SG9999015952.SGD","LU0320764599.SGD","LU0820561818.USD","LU0052750758.USD","LU1188198961.HKD","BK0188","LU0509642566.USD","LU0708995153.HKD","LU0505663152.USD","LU0979878070.USD","LU2403377893.USD","BK1582","LU0516422366.SGD","LU1720051108.HKD","SG9999014674.SGD","TSLO","BK0183","02333","IE00BZ08YS42.EUR","LU0234570918.USD","LU0143863784.USD","LU1548497426.USD","IE00BJLML261.HKD","LU2063271972.USD","TSDD","LU1720050803.USD","LU2471134879.HKD","LU0819123356.HKD","LU2097828631.EUR","LU2420271590.USD","BK4551","LU0823426480.USD","LU0823426308.USD","SG9999015945.SGD","IE00BZ08YR35.GBP","BK4574","LU1551013425.SGD","LU2456880835.USD","LU2896262040.SGD","LU2097828557.USD","BYDDY","LU0588546209.SGD","LU1435385759.SGD","LU1508157978.USD","LU0634319403.HKD","LU1064131003.USD","LU0097036916.USD","LU1145028129.USD","BK4548","LU0633140727.USD","LU2168564495.EUR","LU2168563687.JPY","LU0289739343.SGD","LU0594300179.USD","LU1366192091.USD","01211","LU0210536198.USD","LU0417516902.SGD","LU1997245094.SGD","LU0823414551.USD","LU2663582299.SGD","BK1167","LU1820825898.SGD","LU1861215975.USD","BK4533","LU2023250330.USD","LU1242518931.SGD","LU0449515922.USD","LU0359201612.USD","LU1868838027.USD","TSLW","LU1961090484.USD","LU0289961442.SGD","BK4543","BK4592","LU0516422952.EUR","BK1509","LU0828238088.HKD","BK4581","BK1540","LU0269904917.USD","LU1719994722.HKD","SG9999002463.SGD","TSYY","LU0198837287.USD","LU1629891620.HKD","LU0211977185.USD","BK1522","82333","LU0964807845.USD","LU2168564149.EUR","00285","LU1861214812.USD","LU0593848301.USD","BK4511","HK0000914686.HKD","LU0820562030.AUD","LU2108987350.USD","LU2357305700.SGD","LU1303224171.USD","LU2360107168.USD","LU1674673691.USD","BK1539","IE00BZ08YT58.USD","LU0605514214.HKD","LU2756315318.SGD","LU0708995401.HKD","LU2250418816.HKD","LU0348825331.USD","LU2097828714.EUR","LU1969619763.USD","LU0274383008.USD","LU1813983027.USD","SG9999006597.SGD","LU0109391861.USD","LU2357125470.USD","LU1023057109.AUD","LU0345769631.USD","002594","IE00BSNM7G36.USD","LU1880383366.USD","LU0449509016.USD","LU2471134796.USD","LU0823414478.USD","601633","IE00B19Z9505.USD","LU0588545904.SGD","LU0633140560.USD","BK0072","LU0466842654.USD","LU2348774022.SGD","LU0588545730.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658516967","title":"Baiyunshan Pharmaceutical Gets Nod to Trial New Indication for Zhangyanming Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2658516967","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658516967?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:41","pubTimestamp":1786430475,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical  received approval from China's ational Medical Products Administration to add a new functional indication for its clinical trial for Zhangyanming Tablets, according to a Shanghai bourse filing on Tuesday.The drug will be tested as a treatment for dry eye disease.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK0175","BK0196","BK0097","00874","BK0096","BK0070","BK0188","BK1521","BK1606","BK1191","BK0028","BK0183","BK0239","600332","BK0012","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166701313","title":"Morning Session Sees Market Divergence With ChiNext Up 1.41%, MLCC and Pharmaceuticals Lead Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1166701313","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166701313?lang=en_us&edition=fundamental","pubTime":"2026-08-11 11:50","pubTimestamp":1786420250,"startTime":"0","endTime":"0","summary":"A-share markets opened lower across the board on August 11, with the three major indices diverging as the ChiNext Index rebounded from lows to gain over 1%, while the Shanghai Composite fluctuated...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","159938","159982","BK1515","399300","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117448157","title":"Hong Kong Stock Moves: Kintor Pharma-B (09939) Surges Nearly 9% Again, Subsidiary Signs Strategic Framework with Shanghai Kangmei for KT-939","url":"https://stock-news.laohu8.com/highlight/detail?id=1117448157","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117448157?lang=en_us&edition=fundamental","pubTime":"2026-08-11 11:22","pubTimestamp":1786418539,"startTime":"0","endTime":"0","summary":"Kintor Pharma-B (09939) shares climbed nearly 9% in early trading, currently up 6.35% to HKD 2.01, with a turnover of HKD 1.8253 million. On August 5, Kintor Pharma's subsidiary, Suzhou Kintor,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004220.SGD","BK1515","BK4585","KT","VXUS","KCAI","BK4588","LU0541501648.USD","09939","LU0541502299.USD","BK1574","BK4115","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658963170","title":"Junshi Biosciences Shareholder Cuts Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2658963170","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658963170?lang=en_us&edition=fundamental","pubTime":"2026-08-11 09:17","pubTimestamp":1786411021,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences'  shareholder, He Ming, sold 882,600 shares for 33.5 million yuan, according to a Tuesday filing.The shares were sold through centralized bidding at prices ranging from 35.76 yuan to 40.34 yuan each between July 3 and Aug. 10.Following the sale, He Ming held 2.65 million shares, or 0.2579% of the company's total share capital, down from 0.3440%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01877","FCA","BK1515","BK1161","BK0239","688180","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149534914","title":"JUNSHI BIO Shareholder He Ming Completes Sale of 882,600 Shares, Fulfilling Reduction Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1149534914","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149534914?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:10","pubTimestamp":1786367411,"startTime":"0","endTime":"0","summary":"JUNSHI BIO (01877) has announced that it recently received a notice from Ms. He Ming regarding the results of her share reduction. Ms. He Ming's planned reduction has been fully executed, with a total of 882,600 shares sold, amounting to approximately 33.54 million yuan.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01877","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658193554","title":"Ascletis Pharma Begins Obesity Drug Candidate Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658193554","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658193554?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:55","pubTimestamp":1786362947,"startTime":"0","endTime":"0","summary":"Ascletis Pharma (HKG:1672) initiated two phase I studies in the U.S. for ASC36 and ASC36_35FDC for the treatment of obesity.The move comes following investigational new drug clearance by the U.S. Food and Drug Administration (FDA), according to a Monday Hong Kong bourse filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK1161","BK1515","01672"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":10,"totalSize":217,"code":"91000000","status":"200"}]}}